Source:http://linkedlifedata.com/resource/pubmed/id/21319970
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1
|
| pubmed:dateCreated |
2011-2-15
|
| pubmed:abstractText |
Circulating tumor cells (CTCs) and tumor-specific alterations in cell-free plasma DNA can both be used as markers of prognosis in breast cancer. To date, there have been no studies that have compared these as markers for subclinical metastases in the follow-up of early breast cancer. In this study, we measured CTCs and plasma DNA in a published group of patients with multiple pulmonary nodules and indeterminate metastatic disease.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Feb
|
| pubmed:issn |
1752-0371
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
5
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
87-91
|
| pubmed:meshHeading |
pubmed-meshheading:21319970-Breast Neoplasms,
pubmed-meshheading:21319970-DNA,
pubmed-meshheading:21319970-Early Detection of Cancer,
pubmed-meshheading:21319970-Female,
pubmed-meshheading:21319970-Humans,
pubmed-meshheading:21319970-Multiple Pulmonary Nodules,
pubmed-meshheading:21319970-Neoplasm Metastasis,
pubmed-meshheading:21319970-Neoplastic Cells, Circulating,
pubmed-meshheading:21319970-Receptor, erbB-2,
pubmed-meshheading:21319970-Tumor Markers, Biological
|
| pubmed:year |
2011
|
| pubmed:articleTitle |
Circulating tumor cells and plasma DNA analysis in patients with indeterminate early or metastatic breast cancer.
|
| pubmed:affiliation |
Department of Cancer Studies & Molecular Medicine, University of Leicester, Leicester Royal Infirmary, UK.
|
| pubmed:publicationType |
Journal Article
|